Search hospitals > Hawaii > Aiea

Pali Momi Medical Center

Claim this profile
Aiea, Hawaii 96701
Global Leader in Parotid Gland Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Cervical Adenocarcinoma
269 reported clinical trials
15 medical researchers
Photo of Pali Momi Medical Center in AieaPhoto of Pali Momi Medical Center in AieaPhoto of Pali Momi Medical Center in Aiea

Summary

Pali Momi Medical Center is a medical facility located in Aiea, Hawaii. This center is recognized for care of Parotid Gland Cancer, Breast Cancer, Lung Cancer, Cancer, Cervical Adenocarcinoma and other specialties. Pali Momi Medical Center is involved with conducting 269 clinical trials across 395 conditions. There are 15 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Jared D. Acoba, Jami A. Fukui, and Michael Carney, MD.

Area of expertise

1Parotid Gland Cancer
Global Leader
Pali Momi Medical Center has run 86 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Pali Momi Medical Center has run 63 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
ER positive
HER2 negative

Top PIs

Clinical Trials running at Pali Momi Medical Center

Breast Cancer
Lung Cancer
Cancer
Ovarian Cancer
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Breast cancer
Pancreatic Carcinoma
Pancreatic Cancer
Small Cell Lung Cancer
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Pali Momi Medical Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security